“If your itching is caused by a liver problem, there won’t be a skin rash or an insect bite,” the Liver Foundation says. The ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

THIS YEAR, the vibrant city of Amsterdam, the Netherlands played host to the European Association for the Study of ...

At the start of the year, there had been no new therapies for rare cholestatic liver disease primary biliary cholangitis ... leading to cirrhosis. It affects around 130,000 people in the US ...

One of the most common causes of liver disease besides alcohol is non-alcoholic fatty liver disease (NAFLD). This happens ...

The FDA has accepted for review the NDA for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

For example, increased frequencies of HLA B8 and DR3 are found in patients with primary sclerosing cholangitis (61,62) and HLA A1-B8-DR3 and DR4 are risk factors for autoimmune hepatitis .

New estimates from the Office for Budget Responsibility (OBR) indicate that 1.64 million people currently claiming Personal ...

Researchers warned of worsening health outcomes and financial strain for the 2 million Americans with hepatitis C if the Supreme Court cancels free preventive care covered by the Affordable Care Act.

Cirrhosis can be the result of chronic alcohol consumption, hepatitis, or other liver-related conditions. ... What Are the Treatment Options for Primary Biliary Cholangitis (PBC)?

Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options.

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is ...